(Q40069386)

17 September 2017

title

Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media (English)

1 reference

17 September 2017

Ghani K

1

1 reference

17 September 2017

Cottin S

series ordinal

2

1 reference

17 September 2017

Kamen A

series ordinal

3

1 reference

17 September 2017

Caruso M

series ordinal

4

1 reference

17 September 2017

publication date

11 October 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

14

1 reference

17 September 2017

issue

24

1 reference

17 September 2017

page(s)

1705-1711

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3303039

17 September 2017

exact match

0 references

cites work

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Targeting tumours with genetically enhanced T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Improved safety and titre of murine leukaemia virus (MLV)-based retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

High efficiency retroviral vectors that contain no viral coding sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Effects of culture parameters on the production of retroviral vectors by a human packaging cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

A novel human suspension culture packaging cell line for production of high-titre retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Optimization of retroviral vector generation for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Closed hollow-fiber bioreactor: a new approach to retroviral vector production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

State-of-the-art of the production of retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in cell factories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Comparison of different bioreactor systems for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Chimeric retroviral helper virus and picornavirus IRES sequence to eliminate DNA methylation for improved retroviral packaging cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34(+) cells increases gene transfer mediated by GALV pseudotyped vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

High translation efficiency is mediated by the encephalomyocarditis virus internal ribosomal entry sites if the natural sequence surrounding the eleventh AUG is retained.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

A safe packaging line for gene transfer: separating viral genes on two different plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

7 January 2021

Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

7 January 2021

High-titer packaging cells producing recombinant retroviruses resistant to human serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

7 January 2021

Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

7 January 2021

Functional assessment of the engraftment potential of gammaretrovirus-modified CD34+ cells, using a short serum-free transduction protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

7 January 2021

Improved methods of retroviral vector transduction and production for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

7 January 2021

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303039

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3303039

1 reference

Dimensions Publication ID

17 September 2017

1050640037

0 references

1 reference